Ilia I. Ouspenski

Array ( [id] => 9009571 [patent_doc_number] => 08524869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Humanized antibodies against LIGHT and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/256425 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 36473 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626655 [patent_doc_number] => 20100172899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'IgM Production by Transformed Cell and Method of Quantifying the Same' [patent_app_type] => utility [patent_app_number] => 12/727162 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21677 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172899.pdf [firstpage_image] =>[orig_patent_app_number] => 12727162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228867 [patent_doc_number] => 20100183605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'TES7 AND ANTIBODIES THAT BIND THERETO' [patent_app_type] => utility [patent_app_number] => 12/724564 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28017 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183605.pdf [firstpage_image] =>[orig_patent_app_number] => 12724564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817476 [patent_doc_number] => 20120064096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'BTLA Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/255977 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12448 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064096.pdf [firstpage_image] =>[orig_patent_app_number] => 13255977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305885 [patent_doc_number] => 08227420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID' [patent_app_type] => utility [patent_app_number] => 12/720064 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 124 [patent_no_of_words] => 48862 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12720064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343567 [patent_doc_number] => 20100330104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METHODS OF USING BTL-II PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/716594 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 30810 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330104.pdf [firstpage_image] =>[orig_patent_app_number] => 12716594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967067 [patent_doc_number] => 07939640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Antibodies that bind B7L-1' [patent_app_type] => utility [patent_app_number] => 12/714246 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14326 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939640.pdf [firstpage_image] =>[orig_patent_app_number] => 12714246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6643657 [patent_doc_number] => 20100227774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Method For Generating and Selecting Antibodies Against Target Protein' [patent_app_type] => utility [patent_app_number] => 12/713357 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30389 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227774.pdf [firstpage_image] =>[orig_patent_app_number] => 12713357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171300 [patent_doc_number] => 20120107320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'ANTIBODIES SPECIFICALLY DIRECTED TO THE SOLUBLE FORM OF CTLA-4' [patent_app_type] => utility [patent_app_number] => 13/203418 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13924 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107320.pdf [firstpage_image] =>[orig_patent_app_number] => 13203418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766237 [patent_doc_number] => 20120034249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Methods for Treating Progressive Multifocal Leukoencephalopathy (PML)' [patent_app_type] => utility [patent_app_number] => 13/201829 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27783 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034249.pdf [firstpage_image] =>[orig_patent_app_number] => 13201829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8163354 [patent_doc_number] => 08173123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Methods of treating colitis involving IL-13 and NK-T cells' [patent_app_type] => utility [patent_app_number] => 12/709029 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16493 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173123.pdf [firstpage_image] =>[orig_patent_app_number] => 12709029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6444230 [patent_doc_number] => 20100144640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'MOLECULES DESIGNATED B7L-1' [patent_app_type] => utility [patent_app_number] => 12/708061 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14262 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144640.pdf [firstpage_image] =>[orig_patent_app_number] => 12708061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270670 [patent_doc_number] => 20100254978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN OX40' [patent_app_type] => utility [patent_app_number] => 12/706993 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21371 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254978.pdf [firstpage_image] =>[orig_patent_app_number] => 12706993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6230101 [patent_doc_number] => 20100184145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/704990 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12331 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184145.pdf [firstpage_image] =>[orig_patent_app_number] => 12704990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493564 [patent_doc_number] => 20100209430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Method for treating erectile dysfunction' [patent_app_type] => utility [patent_app_number] => 12/704235 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1579 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209430.pdf [firstpage_image] =>[orig_patent_app_number] => 12704235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530831 [patent_doc_number] => 20100221258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent' [patent_app_type] => utility [patent_app_number] => 12/701128 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26121 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221258.pdf [firstpage_image] =>[orig_patent_app_number] => 12701128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412639 [patent_doc_number] => 20100166762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHOD OF TREATING A PATHOLOGICAL SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/701197 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73469 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166762.pdf [firstpage_image] =>[orig_patent_app_number] => 12701197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7997577 [patent_doc_number] => 08080636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'BSL3 antibodies' [patent_app_type] => utility [patent_app_number] => 12/701119 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 46 [patent_no_of_words] => 43638 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080636.pdf [firstpage_image] =>[orig_patent_app_number] => 12701119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228874 [patent_doc_number] => 20100183612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHODS OF TREATMENT USING CTLA4 MUTANT MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/694327 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13674 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183612.pdf [firstpage_image] =>[orig_patent_app_number] => 12694327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228833 [patent_doc_number] => 20100183571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'TREATMENT OF MULTIPLE SCLEROSIS USING PLACENTAL STEM CELLS' [patent_app_type] => utility [patent_app_number] => 12/687851 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 34251 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183571.pdf [firstpage_image] =>[orig_patent_app_number] => 12687851 [rel_patent_id] =>[rel_patent_doc_number] =>)